A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects

Clinical trial NCT00821561 · WITHDRAWN

Trial details

NCT number: NCT00821561
Sponsor: OcuNexus Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Persistent Epithelial Defect

Start date: 2009-03-01
Primary completion: 2009-11-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.